Arboretum Launches to Redefine Precision Medicine for Common Diseases as a Next-generation Molecular Information Company

Arboretum LifeSciences launched with Series A financing led by F-Prime, GV, .406 Ventures, Hims & Hers, Amgen and other healthcare investors. The company combines genetic testing and molecular information to support precision medicine and clinical research.